一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

??????

??????
?????? ??? ???
?? ??:
96829-58-2
???:
??????
???(??):
??????
???:
Orlistat
???(??):
Orlistate;XENICAL;aolisita;Orlistat Powder;oristat;Orlipastat, Orlistat;ORLISTAT PELLETS 50%;Orlistat Pellets 50%;N-FORMYL-L-LEUCINE (1S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]DODECYL ESTER;(S)-(S)-1-((2S,3S)-3-Hexyl-4-oxooxetan-2-yl)tridecan-2-yl 2-formamido-4-methylpentanoate
CBNumber:
CB2431985
???:
C29H53NO5
??? ??:
495.73
MOL ??:
96829-58-2.mol
MSDS ??:
SDS

?????? ??

???
<50 °C
?? ?
615.9±30.0 °C(Predicted)
??
D20 -32.0° (c = 1 in chloroform)
??
0.976±0.06 g/cm3(Predicted)
?? ??
2-8°C
???
DMSO: 19mg/mL
??? ??
??
??? ??
??? ??
?? ?? (pKa)
14.59±0.23(Predicted)
??
???
???? ??
synthetic (organic)
Merck
14,6869
???
??? ?? ?????? 1? ?? ??????. DMSO ?? ??? ??? -20°?? ?? 1?? ?? ??? ? ????.
InChIKey
AHLBNYSZXLDEJQ-FWEHEUNISA-N
SMILES
C(O[C@H](C[C@H]1[C@H](CCCCCC)C(=O)O1)CCCCCCCCCCC)(=O)[C@H](CC(C)C)NC=O
CAS ??????
96829-58-2(CAS DataBase Reference)
??
  • ?? ? ?? ??
  • ?? ? ???? ?? (GHS)
WGK ?? 3
RTECS ?? OH3167600
HS ?? 29322090
???? ??? 11 - Combustible Solids
?? ?? ??? 96829-58-2(Hazardous Substances Data)
????(GHS): Exclamation Mark (GHS07)
?? ?: Warning
??·?? ??:
?? ??·?? ?? ?? ?? ?? ?? ? ?? ?? P- ??
H302 ??? ??? ?? ?? ?? - ?? ?? 4 ?? P264, P270, P301+P312, P330, P501
H412 ??? ??? ?? ????? ??? ?? ????? ?? - ?? ?? 3 P273, P501
??????:
P273 ???? ???? ???.
NFPA 704
0
2 0

?????? MSDS


(-)-Tetrahydrolipstatin

?????? C??? ??, ??, ??

??

Orlistat? ??? ????? ???? ??? ??? ????? ???? ???? ?? ??? ?? ?????. ?? ?? ?? ?? ??? ?????, ??? ??? ?? ??? ??? ?? ?? ?? ?? ??? ?? ?????? ????. ?? ??? ???? ???? ???? ???? ?? ?? ??? ??? ???? ?? ??? 2-3 ???? ? ?? ? ????.

??

Orlistat? ?? ???? ?? ? ??? ?? ??? ??? ??? ??? ??? ????? ??? ? ?????? ????. ??? ?? ?? ??? ??? ??? ??? ??? ???? ??? ????? 2 ? ???? ??? ????? ??? ????.

??

Orlistat was launched in the UK as Xenical for the long-term treatment of obesity, preferably in conjunction with a moderately reduced calorie diet. Orlistat is a tetrahydro-derivative of the natural hypolipaemic lipstatin (from Streptomyces toxyfncini) and can be obtained either by hydrogenation of lipstatine or by several different synthetic ways involving many steps from ( S ) - rnalic acid. Orlistat is a potent inhibitor of gastrointestinal lipases required for the lipolysis and digestion of dietary fat, in particular of pancreatic lipase ; as a result, it prevents the absorption of about one third of the fat contained in food and acts as an effective weight-reducing therapy. The outcomes of several clinical trials involving thousands of obese patients showed that Orlistat promotes a significant weight loss (often between 5 and 10% after one year) and improves cardiovascular risk factors such as total cholesterol, LDL/HDL ratio, blood glucose levels, insulin, blood pressure. Orlistat has minimal systemic absorption, the majority of the compound itself being recovered in the feces ; it does not affect other gastrointestinal processes, or the absorption of other rnacronutrients such as carbohydrates and proteins.

??? ??

Off-White Solid

??

Orlistat is an antiobesity agent. Orlistat is an pancreatic lipase inhibitor.

?? ??

Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Orlistat is a specific lipase inhibitor derived from lipostatin, which is naturally produced by Streptomyces toxytricini. Lipase inhibition induced by orlistat reduces the absorption of dietary fat, thereby contributing to caloric deficit.

???? ??

Hypolipemic pancreatic, gastric and carboxylester lipase inhibitor. Exhibits no activity at phospholipase A 2 , liver esterase, trypsin and chymotrypsin. Inhibits the thioesterase domain of fatty acid synthase, leading to cell cycle arrest at the G 1 /S boundary in vitro . Prevents the absorption of approximately one third of fat from food and exhibits progastrokinetic, antiobesity and antihypercholesterolemic activity in vivo .

?????? ?? ?? ? ???

???

?? ??


?????? ?? ??

???( 822)?? ??
??? ?? ??? ?? ?? ? ??
Xi'an ZB Biotech Co.,Ltd
+86-18591943808
sales01@xazbbio.com China 815 58
Apeloa production Co.,Limited
+86-19131931000
admin@apcl.com.cn China 861 58
Shaanxi Cuikang Pharmaceutical Technology Co., Ltd.
+86-13119157289; +86-13119157289
13119157289@163.com China 998 58
.GZ HONESTCHEM CO.,LTD
+86-15013270415
honestchemical@foxmail.com China 300 58
Hebei Chuanghai Biotechnology Co., Ltd
+86-15350571055
Sibel@chuanghaibio.com China 8738 58
Shaanxi Dideu Medichem Co. Ltd
+86-29-81139210 17389186172
1077@dideu.com China 3796 58
Hebei Yanxi Chemical Co., Ltd.
+86-17531190177
faithe@yan-xi.com China 5853 58
Anhui Yiao New Material Technology Co., Ltd
+86-18033737140 +86-17354101231
sales1@hbganmiao.com China 227 58
Henan Bao Enluo International TradeCo.,LTD
+86-17331933971
deasea125996@gmail.com China 2472 58
Shandong Huisheng Import & Export Co., Ltd.
+86-13176845580
da@zhongda-biotech.com China 232 58

?????? ?? ??:

Copyright 2019 ? ChemicalBook. All rights reserved
信宜市| 任丘市| 布拖县| 宜兰县| 凤山市| 玉树县| 巨鹿县| 镇赉县| 基隆市| 库尔勒市| 绥化市| 堆龙德庆县| 龙岩市| 榆林市| 星子县| 筠连县| 凤冈县| 拉萨市| 徐闻县| 永丰县| 大安市| 昌吉市| 大邑县| 桐柏县| 宜州市| 彰武县| 汪清县| 岐山县| 永泰县| 遵义市| 美姑县| 印江| 尼玛县| 呼伦贝尔市| 当雄县| 冀州市| 巨鹿县| 溆浦县| 香港| 松原市| 江口县|